New Zealand markets closed

ProMIS Neurosciences, Inc. (PMN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.6133-0.0167 (-1.02%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-16,898
-18,062
-9,790
-4,441
-5,662
Depreciation & amortisation
4.697
11.216
45.825
12.3341
6.553
Stock-based compensation
405.47
487.63
515.629
205.3531
495.605
Change in working capital
6,745
5,403
-1,564
688.1058
498.09
Accounts receivable
-
-
-
27.1605
-14.9701
Accounts payable
6,597
2,676
-31.654
72.7877
-131.1903
Other working capital
-11,639
-17,036
-9,311
-3,500
-4,662
Other non-cash items
-
241.854
366.018
-
-
Net cash provided by operating activities
-11,639
-17,034
-9,305
-3,415
-4,662
Cash flows from investing activities
Investments in property, plant and equipment
-
-1.981
-6.044
-85.2175
-
Acquisitions, net
-
-
-
-2.3526
0
Purchases of investments
-
-31.009
-33.102
-32.9653
-32.0194
Sales/maturities of investments
-
31.009
33.069
32.8006
31.8602
Other investing activities
-
-
2.36
-
-
Net cash used for investing activities
0.043
-1.981
94.618
-87.7349
-0.1592
Cash flows from financing activities
Common stock issued
23,234
4,974
15,868
0
4,034
Common stock repurchased
-
-
-1,644
-
-
Net cash used provided by (used for) financing activities
24,754
6,495
25,523
3,007
4,105
Net change in cash
12,948
-11,068
16,137
-496.2083
-557.2653
Cash at beginning of period
3,921
16,944
806.887
1,303
1,829
Cash at end of period
17,036
5,876
16,944
806.9325
1,272
Free cash flow
Operating cash flow
-11,639
-17,034
-9,305
-3,415
-4,662
Capital expenditure
-
-1.981
-6.044
-85.2175
-
Free cash flow
-11,639
-17,036
-9,311
-3,500
-4,662